SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending as the market keenly anticipates a pivotal Department of Energy announcement regarding surplus plutonium awards, a key catalyst for its advanced nuclear technology. Bullish sentiment is driven by expectations of government support and institutional accumulation during a perceived oversold period. Conversely, bears emphasize substantial insider selling and ongoing share dilution, raising concerns about the company's valuation given its current lack of commercial revenue.

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

EKSO is experiencing significant upward momentum and trading volume following the announcement of a proposed business combination with Applied Digital's cloud division, forming a new AI compute platform, ChronoScale. The community is actively discussing this pivot into AI infrastructure, with many anticipating a substantial short squeeze despite lingering concerns about potential dilution. This move highlights EKSO's transformation into a key player in the rapidly expanding AI sector.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is experiencing significant volatility and trending amid intense community debate. A recent sharp rebound from declines, attributed by many to alleged manipulation via margin calls, is fueling discussion of a potential short squeeze. The market is buzzing with anticipation over imminent silver export restrictions from China, effective January 1st, 2026, which bulls believe will profoundly impact supply and drive prices higher due to rising industrial demand.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending fueled by its highly engaged community, passionately advocating for the "OG meme" narrative of Rage Comics and actively building out an ecosystem with tools like RageMaker and RageGames. This dedicated base expresses strong conviction, viewing RAGE as significantly undervalued and poised for substantial long-term growth as they lead a "return to the memes" within the broader market upswing.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amidst a persistent downtrend that has frustrated many investors, fueling community discussion around market manipulation and the stock's daily declines. Despite this bearish sentiment, bulls highlight the company's international expansion, AI integration, and a share buyback program as strong long-term catalysts. The market is weighing Hims' direct-to-consumer model and GLP-1 strategy, particularly after the FDA approval of Novo Nordisk's oral weight-loss pill, creating a divide between those seeing a buying opportunity and those questioning its immediate prospects.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending due to significant community debate and anticipation surrounding potential positive announcements at the upcoming CES 2026. While many investors express frustration over recent price declines, a bullish contingent highlights analyst upgrades, institutional buying, and the company's strong fundamentals in agentic AI voice solutions for automotive and restaurant sectors, viewing current levels as a strategic buying opportunity for long-term growth.

BUUU Group Ltd. is a holding company, which operates through its subsidiaries, BU Creation and BU Workshop. Its subsidiaries engage in design, planning and production of face-to-face events, immersive environments and brand-based experiences for clients and venues, including event organizers, consumer brand marketers and retail shopping centers. The company was founded in 2017 and is headquartered in Hong Kong.

BUUU Group Ltd. - Ordinary Shares - Class A

BUUU Group Ltd

BUUU Group Ltd is experiencing extreme volatility and intense speculative trading, driven by comparisons to other high-flying, low-float Chinese stocks. While many traders are actively chasing rapid gains, a significant portion of the community warns of a potential pump and dump scenario, fueling a highly divided discussion.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending following positive Phase 3 trial data for its relacorilant candidate in platinum-resistant ovarian cancer, sparking community debate over market valuation and intense short-seller activity. Investors are also focused on an upcoming regulatory decision for relacorilant in Cushing's syndrome and promising survival data from its ALS program, fueling discussions about the company's long-term growth and potential for a significant short squeeze.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending with high anticipation for multiple imminent FDA decisions, including a PDUFA date for its motion sickness drug, Tradipitant, and an expedited re-review for Hetlioz in jet lag. The community is actively discussing Tradipitant's significant potential in addressing GLP-1 induced nausea, viewing these regulatory catalysts as crucial for a re-rating given the company's improved relationship with the FDA. Investors are keenly watching for outcomes that could lead to considerable stock movement, drawing comparisons to other recent biotech approvals.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies is trending on expectations of a significant refinancing wave and broader housing market recovery as monetary policy is anticipated to ease, positioning its integrated mortgage and fintech platform for growth. Community discussions highlight the company's strong technical setup, strategic advantages from its full ecosystem including Mr. Cooper and Redfin, and the potential for increased operating leverage through AI-driven efficiency. While many foresee substantial upside from cycle normalization, some caution against expecting a repeat of past rapid price movements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is This the Right Time to Bet on Clean Energy ETFs?

Despite policy headwinds, surging AI-driven power demand and falling renewable costs are powering clean energy ETFs higher.

FuelCell Energy (FCEL) shares jumped as much as 29% at the opening bell on&nbsp;Friday after&nbsp;the company reported a surge in revenue&nbsp;and laid out a major restructuring plan to reduce costs and concentrate on its carbonate platform.FuelCell Energy reported a loss of $1.79 per share in the second quarter (Q2), an improvement over the same period last year and&nbsp;wider than the estimated loss of $1.38 per share, according to Koyfin data.Its revenue grew 67% year-on-year (YOY) to $37.4 million, coming in ahead of Wall Street’s estimate of $32 million. Management said the growth was driven by new product and&nbsp;service contract activity.&nbsp;Product revenue was $13 million compared with none in the prior-year period, while service agreements generated $8.1 million, helped by module replacements under a contract with United IlluminatingGeneration revenue declined to $12.1 million from $14.1 million, reflecting lower power output due to maintenance. Advanced technologies contract revenue also fell to $4.1 million from $6.9 million,&nbsp;partly due to reduced revenue from contracts with ExxonMobil affiliates and government agencies.The company announced a new restructuring initiative&nbsp;that will affect operations in the U.S., Canada, and Germany.&nbsp;FuelCell said the move is intended to reduce operating costs, prioritize carbonate platform development, and preserve competitiveness in a slower investment environment for clean energy.&nbsp;The plan includes a 22% reduction in workforce, bringing global headcount to approximately 426.This follows a November 2024 restructuring that targeted a 15% reduction in fiscal 2025 operating costs and included a 13% workforce cut along with trimmed spending on product development and overhead.CEO Jason Few said the company is prioritizing its core carbonate technology in response to demand from AI data centers and distributed power solutions. FuelCell is also scaling back commercial development of solid oxide platforms and trimming SG&amp;A expenses to improve its financial trajectory.CFO Michael Bishop&nbsp;highlighted the company’s ongoing cost discipline and pursuit of strategic financing.&nbsp;Cash and equivalents, including restricted cash and short-term investments, totaled $240 million at the end of the quarter, down from $318 million in October 2024.FuelCell ended the quarter with $1.26 billion in backlog, up 19% from a year earlier, supported by a long-term service agreement with Gyeonggi Green Energy in South Korea and a new 20-year power purchase agreement for a 7.4-MW fuel cell plant in Connecticut.<a href="https://stocktwits.com/symbol/FCEL">FuelCell’s stock</a> is down 77% over the past 12 months and 30% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-not-interested-in-call-with-elon-musk-say-reports/chkzrevRbUc">Trump ‘Not Interested’ In Call With Elon Musk, Say Reports</a>

The JFB Fuel Cell Power Plant, manufactured by FuelCell Energy, Inc., is unveiled at the headquarters (L) of the Los Angeles Department of Water and Power March 14, 2003 in Los Angeles, California. (Photo by David McNew/Getty Images)

FuelCell Stock Jumps Despite Q2 Earnings Miss On Revenue Surge, New Restructuring Plan

FuelCell’s restructuring plan includes a 22% reduction in workforce, bringing global headcount to approximately 426.

PBD
Invesco Global Clean Energy ETF

Feed

News

Sentiment

Fundamentals

Info

Latest PBD News

PBDInvesco Global Clean Energy ETF